Home > Naviscan Salary

Naviscan Salary

  • 79
  • 91
  • 78
Naviscan average salary is $132,000, median salary is $132,000 with a salary range from $132,000 to $132,000.
Naviscan salaries are collected from government agencies and companies. Each salary is associated with a real job position. Naviscan salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
132,000
Average
132,000
Median
132,000
High
132,000
Total 1 Naviscan Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Business Analyst 132,000-132,000 SAN DIEGO, CA, 92121 2012 Naviscan Business Analyst Salaries (1)
Naviscan SAN DIEGO, CA Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Naviscan salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Naviscan Jobs
See more Naviscan Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Naviscan... Information
  • Naviscan
  • Industry: Scientific
  • City: San Diego, CA
  • Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan¡¯s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.